Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid

Abstract

A composition comprising quercetin, myricetin and chlorogenic acid for treating diabetes and metabolic disorders, and for achieving weight loss in a subject comprising a combination of naturally occurring compounds is provided.

Description

[0001] This application claims the benefit of US Provisional Application No. 60 / 895,486, filed March 19, 2007, which is hereby incorporated in its entirety. Background technique [0002] According to the American Heart Association, more than 60 percent of men and almost 50 percent of women are overweight. In addition, nearly 13% and 18% of men and women were relatively obese. Being sedentary and being overweight can lead to metabolic syndrome, which is a group of metabolic risk factors in a person. These include: (a) central obesity, manifested by excess abdominal and periabdominal adipose tissue; (b) atherogenic dyslipidemia (dyslipidemia, primarily high triglycerides and low HDL cholesterol, which produces plaque buildup in the artery walls); (c) elevated blood pressure (130 / 85 mmHg or higher); (d) insulin resistance or glucose intolerance (the body's inability to use insulin or blood sugar properly); (e ) a prothrombotic state (eg, high fibrinogen in the blood or a plasmi...

AI Technical Summary

Problems solved by technology

To reap the many flavonoid health benefits, large doses are re

Images